October 29 (SeeNews) - Austria's Erste Bank on Wednesday said it maintained its recommendation on Slovenian blue-chip drug maker Krka at 'buy', but cut its target price slightly to 118.5 euro ($151) per share to reflect a recent slump in the company’s share price.